Alpha Centric Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 30,000 shares of AMPH stock, worth $1.11 Million. This represents 1.23% of its overall portfolio holdings.
Number of Shares
30,000
Previous 25,000
20.0%
Holding current value
$1.11 Million
Previous $1 Million
45.5%
% of portfolio
1.23%
Previous 0.83%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$219 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$99.9 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$78.7 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$71.7 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$59.5 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.81B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...